skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

P041 Barriers and Facilitators to Antiretroviral Therapy Initiation and Adherence in Indonesia: Health Care Provider’s Perspectives

Sexually transmitted infections, 2021-07, Vol.97 (Suppl 1), p.A71-A71 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1368-4973 ;EISSN: 1472-3263 ;DOI: 10.1136/sextrans-2021-sti.187

Full text available

Citations Cited by
  • Title:
    P041 Barriers and Facilitators to Antiretroviral Therapy Initiation and Adherence in Indonesia: Health Care Provider’s Perspectives
  • Author: Hutahaean, B ; Stutterheim, S ; Jonas, K
  • Subjects: Antiretroviral drugs ; Bureaucracy
  • Is Part Of: Sexually transmitted infections, 2021-07, Vol.97 (Suppl 1), p.A71-A71
  • Description: BackgroundIndonesia has the fourth-largest number of new HIV diagnoses per year worldwide, is the only country in the Asia-Pacific region where HIV prevalence is increasing, and the WHO aims of 90–90–90 has not yet been reached. It is therefore important to investigate barriers and facilitators to antiretroviral (ARV) therapy initiation and adherence. This study set out to delineate these barriers and facilitators from the perspective of health care providers.MethodsBetween March and May 2020, 20 semi-structured interviews were conducted with health care providers in Indonesia. Thematic analyses were subsequently conducted to ascertain categories of barriers and facilitators to initiation and adherence.ResultsMain facilitators to ARV initiation and adherence were social support; good client-provider communication; less bureaucracy or easy access to ARV; and sufficient HIV and ARV knowledge among people with HIV. Additionally, the use of euphemistic terminology for ARV was a facilitator for adherence, but not for initiation; whereas having sufficient self-care motivation, a desire to live or having health goals, and HIV status acceptance were facilitators to initiation but not adherence.Barriers to initiation and adherence included stigma; complicated bureaucracy; insufficient health care facilities, health care coverage or ARV supply; and distance to clinics. Side effects and experiencing regimens as tedious were additional barriers to adherence; and being in denial, being asymptomatic, fatalism, and the influence of anti-ARV social media were additional barriers to initiation.ConclusionBarriers and facilitators to initiation and adherence occur on various socio-ecological levels and should therefore be targeted on structural, interpersonal, and individual levels. Health care providers can play a key role in promoting facilitators and reducing barriers, but must be supported by national and organizational level efforts that increase access to HIV clinics and health care coverage, and decrease bureaucracy and community-level initiatives that correct myths and misinformation.
  • Publisher: London: BMJ Publishing Group LTD
  • Language: English
  • Identifier: ISSN: 1368-4973
    EISSN: 1472-3263
    DOI: 10.1136/sextrans-2021-sti.187
  • Source: AUTh Library subscriptions: ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait